Intel's Terafab Hopes Dim as Musk Courts TSMC
💡 Key Takeaway
Intel's exclusive Terafab partnership is at risk as Musk confirms TSMC could join, undermining a key catalyst for Intel's foundry turnaround and making its lofty valuation hard to justify.
Musk's Terafab Twist: TSMC in the Mix
Intel shareholders got a jolt when Elon Musk confirmed that Taiwan Semiconductor Manufacturing (TSMC) could play a role in the Terafab joint venture, a project Musk announced to vertically integrate chip production for SpaceX and Tesla. Intel had joined Terafab the day after Musk's initial announcement, sparking a rally in Intel stock and boosting interest in its foundry services.
The Terafab venture aims to produce chips for Musk's companies, which need massive compute power for projects like orbital data centers and Tesla's Optimus robot. Musk's plan is not to compete with foundries but to secure dedicated capacity. Intel was initially seen as the exclusive partner, a vote of confidence for its advanced 14A process.
However, a report by Tim Culpan, confirmed by Musk, indicates TSMC could provide secondary manufacturing expertise and capacity. This news casts doubt on Intel's exclusive role and highlights the competitive threat from TSMC, the world's leading chipmaker.
TSMC's potential involvement makes strategic sense: it could receive financial backing for new Texas facilities and secure a major customer, while also preventing Intel from gaining ground in the foundry market. For Intel, losing Terafab would be a significant setback for its foundry ambitions.
Why Intel's Foundry Future Hangs in the Balance
Intel's foundry business is critical to its turnaround, but it's currently propped up by internal demand. Last quarter, Intel's foundry generated $5.8 billion, up 31% year over year, but $5.5 billion came from Intel's own chipmaking. To sustain and grow the foundry, Intel desperately needs external customers.
The Terafab partnership was seen as a major catalyst, potentially providing an anchor customer for Intel's 14A process. Intel has pulled forward its 14A timeline and plans to deliver its process design kit to customers this month, with risk production next year and volume production in 2028. However, recent comments from Intel's foundry CTO suggest 14A performance may only be within 5% of TSMC's A14, raising doubts about Intel's technological edge.
If TSMC wins the Terafab node, Intel's foundry business could face a huge setback, making it even harder to attract external customers. The stock has already run up 163% since April and trades at 63 times forward earnings, pricing in high expectations. The potential loss of Terafab as a catalyst could trigger a significant correction.
While Intel could still remain a leading partner for Terafab, with TSMC providing ancillary services like advanced packaging, the risk is that Intel's role diminishes. Investors need to weigh the possibility that Intel's foundry dreams may not materialize as hoped.
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight
Avoid Intel at current levels; the risk of losing the Terafab catalyst is too high given the stock's stretched valuation.
Intel's foundry turnaround hinges on securing external customers like Terafab, and TSMC's potential involvement significantly reduces that likelihood. With the stock up 163% since April and trading at 63x forward earnings, expectations are sky-high, leaving little room for error. Until there's clarity on Terafab and Intel's 14A competitiveness, the risk-reward is unfavorable.
What This Means for Me
